Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer. - Test2 - elhamkhani - TriplyDB

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

http://www.wikidata.org/entity/Q33462003

about

Identification of novel cholesteatoma-related gene expression signatures using full-genome microarrays Inhibitor of DNA binding 4 (ID4) regulation of adipocyte differentiation and adipose tissue formation in mice Type II arginine methyltransferase PRMT5 regulates gene expression of inhibitors of differentiation/DNA binding Id2 and Id4 during glial cell differentiation Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN Id2, Id3 and Id4 overcome a Smad7-mediated block in tumorigenesis, generating TGF-β-independent melanoma.Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancer.TGF-β mediated DNA methylation in prostate cancer.Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer Clinical implications of the quantitative detection of ID4 gene methylation in myelodysplastic syndrome.Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR.Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B Id4 promotes cell proliferation in hepatocellular carcinoma.Prostate cancer epigenome.Inhibitor of differentiation 4 (ID4): From development to cancer Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.Epigenetic role of CCAAT box-binding transcription factor NF-Y on ID gene family in human embryonic carcinoma cells.Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.Id4 dependent acetylation restores mutant-p53 transcriptional activity.Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells.The Id-protein family in developmental and cancer-associated pathways.U-2932: two clones in one cell line, a tool for the study of clonal evolution.Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease.ID4 is frequently downregulated and partially hypermethylated in prostate cancer.Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growth ID4: a new player in the cancer arena.Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.ID4 promotes AR expression and blocks tumorigenicity of PC3 prostate cancer cells.Progastrin stimulates colonic cell proliferation via CCK2R- and β-arrestin-dependent suppression of BMP2.Inhibitor of differentiation-4 (Id4) stimulates pigmentation in melanoma leading to histiocyte infiltration.ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling.Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.

P2860

Q28484501-485FC050-D297-45F3-B9E7-2BDD0A83C739 Q28513950-433BB5FB-4427-40A4-BB42-C7E7729468AC Q28582796-0BB393F8-4358-4069-AB6B-9A18733FCFFE Q28592943-473F6A0F-B457-4FBC-BC22-95026B74B97A Q33652300-48CD9BB4-2F3B-4ABE-AC2F-34CA354DC861 Q33977414-6AA6A4C3-C82D-4CBA-A2A8-1510BB4EF9FB Q34039935-F8234E25-BD82-435A-9CA0-202B4220AF79 Q34557974-A87F11ED-1F93-4747-833E-B346549EA72A Q34559594-B9067D49-6CD8-4B0C-8894-8F022E932989 Q35108501-6C50696F-B5F2-47DE-90B1-BDD9BF00E710 Q35553504-86402220-0E36-43D9-9461-DFC02A01D183 Q36149242-C0C41469-5DAB-4B59-9B1B-7C8B74216556 Q36477232-E9AD2294-124D-4F79-9086-8EC5D623C1C9 Q36530658-49B7831C-4029-48C6-91AF-E4052AA64B1C Q37618601-B2FE233F-0A01-4D81-962E-AF23ECDCCE7E Q38271076-6FC48C73-C733-46DA-AC3B-C552588982D4 Q38289940-B3387670-ED59-4D16-B36E-14D2D73577F1 Q38714216-229C623A-4A40-4B50-8B8D-514847CB5584 Q38824214-5C3CB160-0AA8-4399-9C66-0E80BC779E6A Q38898841-0751F9D9-49C0-4EA1-9209-B4C09F5A8D79 Q38966904-90BDE81F-2210-48F4-B90E-E8BAA5D73A24 Q39044368-805F51C9-7142-4AA0-AD25-3DB1CCFB91E4 Q39079539-160F5D87-1AEB-49F5-A44D-A594081FB62A Q39103288-C7C579EB-FE50-4D3D-AB1E-F8A6F1C1EC22 Q39215117-257F9BC9-B064-4965-A4D6-792C7865C430 Q39260860-D054DA1E-A367-4791-A3EB-EB86A462B83B Q39406777-BCB482BD-F4C8-4A07-AB7F-7D5041CE06D2 Q39481269-C16F3894-F900-4616-A88E-9B77FAF3D40A Q39529516-73DAC07D-1FAA-436A-87C8-83C890A1E521 Q40580196-B6CAC389-8A31-4F52-9BE4-D41138801D27 Q41241298-3D8EA2EE-FD61-4131-A1A1-98E6A1F4B7A2 Q41554763-E92DDD2C-4ABF-4EC1-A042-7B6FCA759FDE Q41821291-3BB2B3CC-B9F6-400B-BB13-4D99B4F019A6 Q42182349-20926737-696B-47BF-917F-B50C0D5F5C1C Q42221019-FA94742D-28CE-4B40-A64B-41564E246775 Q52620979-6CD65051-2792-4D16-B78F-51EE06CDFCC7

P2860

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

http://www.wikidata.org/entity/Q33462003

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

@ast

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

@en

type

label

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

@ast

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

@en

prefLabel

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

@ast

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

@en

P1433

Q33462003-3087D0AC-31A1-477E-9351-21E1D2BF4378

P1476

Q33462003-EF00A6B2-A96A-4EE5-91DD-4A5B6AC36140

P2093

Q33462003-28BFFCA1-9404-468A-B614-B09E06ECC1CF

Q33462003-41BAB499-9CFF-48E9-9CF6-61FB36155D93

Q33462003-670C70E6-1578-433D-B4B8-F9B0BD9D3E28

Q33462003-CB692809-0BE5-4D37-9E77-50660A88EDD1

Q33462003-FB8BF7E8-CC2B-4975-9D67-3397381CB2AF

P2860

Q33462003-05382C64-1277-473C-B6E5-D8A0640C45CC

Q33462003-0DB6AF32-24C8-4D80-900F-3821AC67C733

Q33462003-1DFFABB5-8289-4D64-8786-114FF1578F18

Q33462003-22A2C347-5EE6-4AD5-A35A-BF93E5BB5272

Q33462003-2B833079-E015-4F6F-90B7-5D1C5FAF8299

Q33462003-2F822ACB-5841-4A3C-BE64-5870BF508559

Q33462003-32CF0ECB-FC8A-44E3-B455-2733F47E75C8

Q33462003-3627EDA2-8479-4933-9F1F-3C1F1FEF3613

Q33462003-378816F4-2543-4AE2-B1AA-D11A2B487931

Q33462003-3CBBEEA3-E5C5-477F-8473-BC796721B3E9

P2888

Q33462003-15A760A2-655D-43EF-A6F5-AE6208347DD3

P304

Q33462003-07A1B03C-E253-452F-95A2-DBA1EC6F5151

P31

Q33462003-086A6DB3-527C-4B50-8C9C-E200E0FE5271

P356

Q33462003-34AEC145-0F26-4764-99C8-816761FF673D

P407

Q33462003-16D64C5D-8F43-416D-B974-32AC793990C4

P478

Q33462003-1C1EF74D-9C31-4F72-80C0-EC9063C6C703

P577

Q33462003-C01A26E0-4C48-4140-B1F2-5421FE7DB863

P5875

Q33462003-49A3DAF4-634C-497A-8293-BA1CC491FB39

P6179

Q33462003-0E12067C-C6BF-4B70-A477-70ADDA94127D

P698

Q33462003-273EB438-8625-48B9-A45E-7CC70D720369

P932

Q33462003-BCF4BD0F-3493-470C-9C93-577E0FA2F35F

P356

1471-2407-9-173

P1433

P1476

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

@en

P2093

Ananthi J Asirvatham

http://www.w3.org/2001/XMLSchema#string

Jaideep Chaudhary

http://www.w3.org/2001/XMLSchema#string

Jason P W Carey

http://www.w3.org/2001/XMLSchema#string

Oliver Galm

http://www.w3.org/2001/XMLSchema#string

Tandeih A Ghogomu

http://www.w3.org/2001/XMLSchema#string

P2860

Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.

Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach

CASK inhibits ECV304 cell growth and interacts with Id1

Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2

A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins

Molecular cloning of ID4, a novel dominant negative helix-loop-helix human gene on chromosome 6p21.3-p22

Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding

Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins

P2888

1471-2407-9-173

P304

173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-9-173

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26270475

http://www.w3.org/2001/XMLSchema#string

P6179

1032068957

http://www.w3.org/2001/XMLSchema#string

P698

19500415

http://www.w3.org/2001/XMLSchema#string

P932

2700118

http://www.w3.org/2001/XMLSchema#string